
Legli 0.3mg Tablet MD
Marketer
LifeCare Formulation Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Legli 0.3mg Tablet MD
Diabetol 0.3mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. It's prescribed when diet and other antidiabetic agents prove insufficient to control elevated blood glucose. Take Diabetol immediately before meals; dosage and frequency are determined by your physician for optimal glycemic control. Abrupt cessation should be avoided; discontinuation without medical supervision may lead to dangerously high blood sugar, potentially causing severe complications like renal impairment and vision loss. This medication is part of a comprehensive treatment plan including dietary modification, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial. Common side effects include abdominal discomfort, altered appetite, bowel irregularities, and flatulence. Report persistent or troubling side effects to your physician. While Diabetol itself doesn't induce hypoglycemia, combining it with other diabetes medications (particularly insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with pure glucose; sucrose is ineffective. Inform your physician of any liver or kidney issues before commencing treatment. Avoid use if you have bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should consult their doctor prior to use. Disclose all other medications to your doctor to ensure safe usage. Limit alcohol consumption to minimize hypoglycemia risk.
Uses of Legli 0.3mg Tablet MD
Managing type 2 diabetes
Major Benefits of Legli 0.3mg Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Avoid handling the tablets with damp hands. Place the Legli 0.3mg Tablet MD in your mouth; however, refrain from swallowing immediately. It should be taken on an empty stomach.
Common Side effects of Legli 0.3mg Tablet MD:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Legli 0.3mg Tablet MD:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth; however, refrain from swallowing it immediately. Legli 0.3mg Tablet MD should be taken on an empty stomach.
How Legli 0.3mg Tablet MD works:
Diabetics may use Legli 0.3mg Tablet MD to manage their condition. This medication works by blocking enzymes in the intestines that digest complex carbohydrates, thus reducing post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Legli 0.3mg Tablet MD is unsafe.
PregnancySAFE IF PRESCRIBED
Use of Legli 0.3mg Tablet MD during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Legli 0.3mg Tablet MD while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Legli 0.3mg Tablet MD.
KidneyCAUTION
Use of Legli 0.3mg Tablet MD requires careful consideration in individuals with advanced kidney impairment. Dosage modification for Legli 0.3mg Tablet MD might be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with severe hepatic impairment, the use of Legli 0.3mg Tablet MD requires careful monitoring. Dosage modification of Legli 0.3mg Tablet MD might be necessary. Physician consultation is advised.
What if you forget to take Legli 0.3mg Tablet MD :
Omit any missed Legli 0.3mg Tablet MD dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Legli 0.3mg Tablet MD
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
| Action Class | Alpha-glucosidase inhibitors |
